Comparative Immunogenicity of Different Multivalent Component Pertussis Vaccine Formulations Based on a 5 Component Acellular Pertussis Vaccine in Infants and Toddlers
Phase of Trial: Phase III
Latest Information Update: 10 Apr 2014
At a glance
- Drugs Hib-DTaP-poliovirus vaccine (Primary) ; DTaP poliovirus vaccine; DTaP vaccine; Hib vaccine conjugate; Poliovirus vaccine inactivated
- Indications Diphtheria; Haemophilus infections; Pertussis; Poliomyelitis; Tetanus
- Focus Pharmacodynamics
- Sponsors Sanofi
- 31 May 2012 Status changed from active, no longer recruiting to completed.
- 24 Sep 2008 Planned end date identified as Apr 2009, as reported by ClinicalTrials.gov.
- 04 May 2008 Primary endpoint 'seroconversion rate' has been met.